FEMALE REPRODUCTIVE SYSTEM AGING: FROM THEORY TO CLINICAL PRACTICE PART 1. THE ENDOCRINE AND CLINICAL CHARACTERISTICS OF FEMALE REPRODUCTIVE SYSTEM AGING STAGES


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The review covers the characteristics of some reproductive aging stages and the association of female endocrine and clinical changes from the late reproductive period to early postmenopause.

Full Text

Restricted Access

About the authors

Svetlana Vladimirovna Yureneva

Academician V.I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia

Email: syureneva@gmail.com
MD, senior researcher in Department of gynecological endocrinology 117997, Russia, Moscow, Ac. Oparina str. 4

Lilia Mikhailovna Ilyina

Association of Gynecological Endocrinology

Email: bseiljina@mail.ru
PhD, secretary 117997, Russia, Moscow, Ac. Oparina str. 4

Vera Petrovna Smetnik

Academician V.I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia

Email: verasmetnik@mail.ru
MD, Professor, Main research fellow in Department of gynecological endocrinology 117997, Russia, Moscow, Ac. Oparina str. 4

References

  1. Harlow S.D., Gass M., Hall J.E., Lobo R., Maki P., Rebar R.W. et al.; STRAW 10 Collaborative Group. Executive summary of the Stages of Reproductive Aging Workshop +10: addressing the unfinished agenda of staging reproductive aging. Menopause. 2012; 19(4): 387-95.
  2. Sowers M.R., Zheng H., McConnell D., Nan B., Harlow S., Randolph J.F. Jr. Follicle stimulating hormone and its rate of change in defining menopause transition stages. J. Clin. Endocrinol. Metab. 2008; 93(10): 3958-64.
  3. Randolph J.F.Jr., Zheng H., Sowers M.R., Crandall C., Crawford S., Gold E.B., Vuga M. Change in follicle-stimulating hormone and estradiol across the menopausal transition: effect of age at the final menstrual period. J. Clin. Endocrinol. Metab. 2011; 96(3): 746-54.
  4. Santoro N., Taylor E.S. Reproductive hormones and the menopause transition. Obstet. Gynecol. Clin. North Am. 2011; 38(3): 455-66.
  5. Santoro N., Brockwell S., Johnston J., Crawford S.L., Gold E.B., Harlow S.D. et al. Helping midlife women predict the onset of the final menses: SWAN, the Study of Women’s Health Across the Nation. Menopause. 2007; 14(3, Pt1): 415-24.
  6. Tehrani F.R., Solaymani-Dodaran M., Tohidi M., Gohari M.R., Azizi F. Modeling age at menopause using serum concentration of Anti-Mullerian Hormone. J. Clin. Endocrinol. Metab. 2013; 98(2): 729-35.
  7. Moilanen J., Aalto A.M., Hemminki E., Aro A.R., Raitanen J., Luoto R. Prevalence of menopause symptoms and their association with lifestyle among Finnish middle-aged women. Maturitas. 2010; 67(4): 368-74.
  8. Lewis У. Undertreatment of menopausal symptoms and novel options for comprehensive management. Curr. Med. Res. Opin. 2009; 25: 2689-98.
  9. Thurston R., Joffe H. Vasomotor symptoms and menopause: findings from the Study of Women’s Health Across the Nation. Obstet. Gynecol. Clin. North Am. 2011; 38: 489-501.
  10. Greenblum C.A., Rowe M.A., Neff D.F., Greenblum J.S. Midlife women: symptoms associated with menopause transition and early postmenopause and quality of life. Menopause. 2013; 20(1): 22-7.
  11. Gast G.C., Grobbee D.E., Pop V.J., Keyzer J.J., Wjnands-van Gent C.J., Samsioe G.N. et al. Menopausal complaints are associated with cardiovascular risk factors. Hypertension. 2008; 51(6): 1492-8.
  12. Bruno R.M., Palagini L., Di Giulio A., Bontempelli L., Virdis A., Gemignani A. et al. Relationship between poor sleep quality and resistant hypertension. In: Presented at American Heart Association High Blood Pressure Research Scientific Sessions. September 21, 2012; Washington, DC; 2012: abstr. 63.
  13. Bromberger J.T., Kravitz H.M. Mood and menopause: Findings from the Study of Women’s Health Across the Nation (SWAN) over ten years. Obstet. Gynecol. Clin. North Am. 2011; 38(3): 609-25.
  14. Cohen L.S., Soares C.N., Vitonis A.F., Otto M.W., Harlow B.L. Risk for new onset of depression during the menopausal transition: the Harvard study of moods and cycles. Arch. Gen. Psychiatry. 2006; 63(4): 385-90.
  15. Mansell D., Salinas G.D., Sanchez A., Abdolrasulnia M. Attitudes toward management of decreased sexual desire in premenopausal women: a national survey of nurse practitioners and physician assistants. J Allied Health. 2011; 4092): 64-71.
  16. Burger H.G., Dudley E.C., Cui J., Dennerstein L., Hopper J.L. A prospective longitudinal study of serum testosterone, dehydroepiandrosterone sulfate, and sex hormone-binding globulin levels through the menopause transition. J. Clin. Endocrinol. Metab. 2000; 85(8): 2832-8.
  17. Dennerstein L., Lehert P., Guthrie J.R., Burger H.G. Modeling women’s health during the menopausal transition: a longitudinal analysis. Menopause. 2007; 14(1): 53-62.
  18. Thurston R.C., El Khoudary S.R., Sutton-Tyrrell K., Crandall C.J., Sternfeld B., Joffe H. et al. Vasomotor symptoms and insulin resistance in the Study of Women’s Health Across the Nation. J. Clin. Endocrinol. Metab. 2012; 97(10): 3487-94.
  19. Thurston R.C., Sutton-Tyrrell K., Everson-Rose S.A., Hess R., Matthews K.A. Hot flashes and subclinical cardiovascular disease: findings from the Study of Women’s Health Across the Nation Heart Study. Circulation. 2008; 118(12): 1234-40.
  20. Thurston R.C., Kuller L.H., Edmundowicz D., Matthews K.A. History of hot flashes and aortic calcification among postmenopausal women. Menopause. 2010; 17: 256-61.
  21. Thurston R.C., Sutton-Tyrrell K., Everson-Rose S.A., Hess R., Powell L.H., Matthews K.A. Hot flashes and carotid intima media thickness among midlife women. Menopause. 2011; 18(4): 352-8.
  22. Thurston R.C., El Khoudary S.R., Sutton-Tyrrell K., Crandall C.J., Gold E., Sternfeld B. et al. Are vasomotor symptoms associated with alterations in hemostatic and inflammatory markers? Findings from the Study of Women’s Health Across the Nation. Menopause. 2011; 18(10): 1044-51.
  23. Thurston R.C., Christie I.C., Matthews K.A. Hot flashes and cardiac vagal control: a link to cardiovascular risk? Menopause. 2010; 17: 456-61.
  24. Donato G.B., Fuchs S.C., Oppermann K., Bastos C., Spritzer P.M. Association between menopause status and central adiposity measured at different cutoffs of waist circumference and waist-to-hip ratio. Menopause. 2006; 13: 280-5.
  25. Davis S.R., Castelo-Branco C., Chedraui P., Lumsden M.A., Nappi R.E., Shah D., Villaseca P.; Writing Group of the International Menopause Society for World Menopause Day 2012. Understanding weight gain at menopause. Climacteric. 2012; 15(5): 419-29.
  26. Tchernof A., Desmeules A., Richard C., Laberge P., Daris M., Mailloux J. et al. Ovarian hormone status and abdominal visceral adipose tissue metabolism. J. Clin. Endocrinol. Metab. 2004; 89(7): 3425-30.
  27. Wildman R.P., Tepper P.G., Crawford S., Finkelstein J.S., Sutton-Tyrrell K., Thurston R.C. et al. Do changes in sex steroid hormones precede or follow increases in body weight during the menopause transition? Results from the Study of Women’s Health Across the Nation. J. Clin. Endocrinol. Metab. 2012; 97(9): E1695-704.
  28. Lee C.G., Carr M.C., Murdoch S.J., Mitchell E., Woods N.F., Wener M.H. et al. Adipokines, inflammation, and visceral adiposity across the menopausal transition: a prospective study. J. Clin. Endocrinol. Metab. 2009; 94(4): 1104-10.
  29. Janssen I., Powel L.H., Kazlauskaite R., Dugan S.A. Testosterone and visceral fat in midlife women: The Study of Women’s Health Across the Nation (SWAN) Fat Patterning Study. Obesity (Silver Spring). 2010; 18(3): 604-10.
  30. Guthrie J.R., Dennerstein L., Taffe J.R., Ebeling P.R., Randolph J.F., Burger H.G., Wark J.D. Central abdominal fat and endogenous hormones during the menopausal transition. Fertil. Steril. 2003; 79(6): 1335-40.
  31. Janssen I., Powell L., Crawford S., Lasley B., Sutton-Tyrrell K. Menopause and the metabolic syndrome. Arch. Intern. Med. 2008; 168: 1568-75.
  32. Torréns J.I., Sutton-Tyrrell K., Zhao X., Matthews K., Brockwell S., Sowers M., Santoro N. Relative androgen excess during the menopausal transition predicts incident metabolic syndrome in midlife women: the Study of Women’s Health Across the Nation. Menopause. 2009; 16(2): 257-64.
  33. Mottillo S., Filion K.B., Genest J., Joseph L., Pilote L., Poirier P. et al. The metabolic syndrome and cardiovascular risk: a systematic review and metaanalysis. J. Am. Coll. Cardiol. 2010; 56(4): 1113-32.
  34. Roger V.L., Go A.S., Lloyd-Jones D.M., Benjamin E.J., Berry J.D., Borden W.B. et al.; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics - 2012 update: a report from the American Heart Association. Circulation. 2012; 125(1): e2-e220.
  35. El Khoudary S.R., Wildman R.P., Matthews K., Thurston R.C., Bromberger J.T., Sutton-Tyrrell K. Endogenous sex hormones impact the progression of subclinical atherosclerosis in women during the menopausal transition. Atherosclerosis. 2012; 225(1): 180-6.
  36. Blümel J.E., Chedraui P., Baron G., Belzares E., Bencosme A., Calle A.; Collaborative Group for Research of the Climacteric in Latin America (REDLINC). Menopausal symptoms appear before the menopause and persist 5 years beyond: detailed analysis of two multinational studies. Climacteric. 2012; 15(6): 542-51.
  37. Management of symptomatic vulvovaginal atrophy: 2013 position statement of the North American Menopause Society. Menopause. 2013; 20(9): 888-902.
  38. Hoshino H., Kushida K., Takahashi M., Yamazaki K., Denda M., Atsumi K. et al. Changes in levels of biochemical markers and ultrasound indices of Os calcis across the menopausal transition. Osteoporos. Int. 2000; 11(2): 128-33.
  39. Crandall C.J., Tseng C.H., Crawford S.L., Thurston R.C., Gold E.B., Johnston J.M., Greendale G.A. Association of menopausal vasomotor symptoms with increased bone turnover during the menopausal transition. J. Bone Miner. Res. 2011; 26(4): 840-9.
  40. Pal L., Norian J., Zeitlian G., Bevilacqua K., Freeman R., Santoro N. Vasomotor symptoms in infertile premenopausal women: a hitherto unap preciated risk for low bone mineral density. Fertil. Steril. 2008; 90(5): 1626-34.
  41. Matthews K.A., Kuller L.H., Chang Y., Edmundowicz D. Premenopausal risk factors for coronary and aortic calcification: a 20-year follow-up in the Healthy Women Study. Prev. Med. 2007; 45: 302-8.
  42. Erbel R., Lehmann N., Möhlenkamp S., Churzidse S., Bauer M., Kälsch H. et al.; Heinz Nixdorf Recall Study Investigators. Subclinical coronary atherosclerosis predicts cardiovascular risk in different stages of hypertension: result of the Heinz Nixdorf Recall Study. Hypertension. 2012; 59(1): 44-53.
  43. Lee M., Saver J.L., Chang B., Chang K.H., Hao Q., Ovbiagele B. Presence of baseline prehypertension and risk of incident stroke: a meta-analysis. Neurology. 2011; 77(14): 1330-7.
  44. De Villiers T.J., Pines A., Panay N., Gambacciani M., Archer D.F., Baber R.J. et al.; International Menopause Society. Updated 2013 International Menopause Society recommendations on menopausal hormone therapy and preventive strategies for midlife health. Climacteric. 2013; 16(3): 316-37.
  45. Eckel R.H., Jakicic J.M., Ard J.D., Miller N.H., Hubbard V.S., Nonas C.A. et al. 2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J. Am. Coll. Cardiol. 2013. Published online November 12, 2013. doi: 10.1016/j.jacc.2013.11.003.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies